Skip to main content
. 2005 May;49(5):1957–1964. doi: 10.1128/AAC.49.5.1957-1964.2005

TABLE 3.

MICs of β-lactams for seven clinical isolates of L. hongkongensis, E. coli XLOLR harboring recombinant plasmid pBK-LHK-5, and E. coli XLOLR

Bacterial strain MIC (μg/ml)b
AMP AMP-CA AMP-SBM FOX CXM CAZ CTX CPZ CPZ-SBM FEP ATM IPM MPM
L. hongkongensis
    HKU1 32 32 16 16 16 >256 64 >256 >256 64 >256 0.0625 0.0625
    HLHK2 128 128 64 128 256 >256 >256 >256 >256 >256 >256 0.0625 0.0625
    HLHK3 256 256 64 64 32 >256 128 >256 >256 32 >256 0.0625 0.03125
    HLHK4 256 256 128 128 64 >256 256 >256 >256 >256 >256 0.0625 0.0625
    HLHK5 256 64 128 64 64 >256 256 >256 >256 128 >256 0.0625 0.0625
    HLHK6 256 256 128 64 16 256 128 >256 >256 128 >256 0.125 0.0625
    HLHK7 64 64 64 64 32 128 128 >256 >256 2 >256 0.0625 0.0625
E. coli
    XLOLR(pBK-LHK-5)a 64 64 32 16 128 64 32 >256 >256 32 >256 0.125 0.0625
    XLOLR 8 4 4 16 32 4 8 8 8 8 128 0.125 0.0625
a

This strain, which harbors the recombinant plasmid pBK-LHK-5, produced the LHK-5 β-lactamase.

b

AMP, ampicillin; AMP-CA, ampicillin plus clavulanic acid (2 μg/ml); AMP-SBM, ampicillin plus sulbactam (4 μg/ml); FOX, cefoxitin; CXM, cefuroxime; CAZ, ceftazidime; CTX, cefotaxime; CPZ, cefoperazone; CPZ-SBM, cefoperazone plus sulbactam (4 μg/ml); FEP, cefepime; ATM, aztreonam; IPM, imipenem; MPM, meropenem.